BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35004009)

  • 21. Impact of inflammatory bowel disease on post-cholecystectomy complications and hospitalization costs: a Nationwide Inpatient Sample study.
    Navaneethan U; Parasa S; Venkatesh PG; Ganapathi TT; Kiran RP; Shen B
    J Crohns Colitis; 2013 Jun; 7(5):e164-70. PubMed ID: 22959005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of irritable bowel syndrome in hospitalized patients with inflammatory bowel disease: Nationwide Inpatient Sample analysis from 2007-2016.
    Shin C; Ali S; Hussain S; Trivedi I; Gao Y; Shuja A
    Ann Gastroenterol; 2022; 35(6):603-608. PubMed ID: 36406967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexisting psoriasis is associated with an increased risk of hospitalization for patients with inflammatory bowel disease: an analysis of the National Inpatient Sample database.
    Edigin E; Asotibe J; Eseaton PO; Busari OA; Achebe I; Kichloo A; Jamal S; Patel A
    J Investig Med; 2020 Dec; ():. PubMed ID: 33361402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and Outcomes of Hospitalized Inflammatory Bowel Disease Patients with Asthma in the United States.
    Khneizer G; Al-Taee A; Mohammed K; Hachem C
    Cureus; 2019 Nov; 11(11):e6127. PubMed ID: 31886065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in hospital admissions and mortality among inflammatory bowel disease patients with substance use disorder: a 10-year United States nationwide analysis.
    Fatakhova K; Patel P; Inayat F; Dhillon R; Ali H; Taj S; Nawaz G; Afzal A; Rehman AU; Afzal MS; Khan R; Ishtiaq R; Jones L; Rajapakse R
    Proc (Bayl Univ Med Cent); 2023; 36(4):427-433. PubMed ID: 37334096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume.
    Ananthakrishnan AN; McGinley EL; Binion DG
    Am J Gastroenterol; 2008 Nov; 103(11):2789-98. PubMed ID: 18684184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of nonalcoholic fatty liver disease on inflammatory bowel disease hospitalizations in the United States.
    Soni A; Yekula A; Dahiya DS; Sundararajan R; Dutta P; Singh Y; Cheng CI; Abraham G
    Ann Gastroenterol; 2023; 36(6):646-653. PubMed ID: 38023970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations.
    Ananthakrishnan AN; McGinley EL; Binion DG
    Inflamm Bowel Dis; 2009 Feb; 15(2):182-9. PubMed ID: 18668678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining the Economic Burden of Perioperative Venous Thromboembolism in Inflammatory Bowel Disease in the United States.
    Lee CHA; Jia X; Lipman JM; Lightner AL; Hull TL; Steele SR; Holubar SD
    Dis Colon Rectum; 2021 Jul; 64(7):871-880. PubMed ID: 33833140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus-related colitis in patients with inflammatory bowel disease.
    Kwon J; Fluxá D; Farraye FA; Kröner PT
    Int J Colorectal Dis; 2022 Mar; 37(3):685-691. PubMed ID: 35132443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inpatient outcomes of inflammatory bowel disease in hospitalized patients with COVID-19: analysis of a nationally representative sample.
    Aldiabat M; Alsakarneh S; Daniel T; Butt MA; Jagdish B; Rock J; Sudan A; Al-Ahmad M; Jabri A; Kilani Y; Odah T; Alhuneafat L; Zulqarnain M; Hashash JG; Ghoz H
    Proc (Bayl Univ Med Cent); 2024; 37(2):239-247. PubMed ID: 38343460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States.
    Nguyen GC; Leung W; Weizman AV
    Inflamm Bowel Dis; 2011 Jun; 17(6):1338-42. PubMed ID: 21560197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bariatric Surgery Is Acceptably Safe in Obese Inflammatory Bowel Disease Patients: Analysis of the Nationwide Inpatient Sample.
    Bazerbachi F; Sawas T; Vargas EJ; Haffar S; Deepak P; Kisiel JB; Loftus EV; Abu Dayyeh BK
    Obes Surg; 2018 Apr; 28(4):1007-1014. PubMed ID: 29019151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Hospital Teaching Status on Outcomes of Patients with Inflammatory Bowel Disease: A Nationwide Analysis.
    Sharma S; Weissman S; Mehta TI; Aziz M; Acharya A; Vohra I; Khan Z; Khan A; Nawras A; Sciarra M; Swaminath A
    Dig Dis Sci; 2021 Jul; 66(7):2216-2226. PubMed ID: 32696235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: a single metropolitan Australian center experience.
    van Langenberg DR; Simon SB; Holtmann GJ; Andrews JM
    J Crohns Colitis; 2010 Oct; 4(4):413-21. PubMed ID: 21122537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal trend in inpatient mortality in inflammatory bowel disease-associated colorectal cancer vs non-inflammatory colorectal cancer: a nationwide retrospective study.
    Flores E; Mbachi C; Achebe I; Asotibe J; Palomera-Tejeda E; Vohra I; Udechukwu V; Kotwal V
    Int J Colorectal Dis; 2021 Apr; 36(4):701-708. PubMed ID: 33063223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014.
    Ramos-Rodriguez AJ; Timerman D; Khan A; Bonomo L; Hunjan MK; Lemor A
    Int J Dermatol; 2018 May; 57(5):547-552. PubMed ID: 29431201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparities in access to minimally invasive surgery for inflammatory bowel disease and outcomes by insurance status: analysis of the 2015 to 2019 National Inpatient Sample.
    Lee Y; Andrew L; Hill S; An KR; Chatroux L; Anvari S; Hong D; Kuhnen AH
    Surg Endosc; 2023 Dec; 37(12):9420-9426. PubMed ID: 37679584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Human Immunodeficiency Virus (HIV) on Inflammatory Bowel Disease (IBD): A Retrospective Nationwide Study.
    Then E; Uhlenhopp DJ; Barakat M; John F; Gayam V; Lopez M; Sunkara T; Gaduputi V
    Curr HIV Res; 2021; 19(5):411-419. PubMed ID: 34053428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.